Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1031 of 1,261
  1. US 7550598

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted
  2. US 7550590

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted
  3. WO 2009076388

    CONJUGUÉS VECTEUR DE CIBLAGE - PHOSPHOLIPIDE

    BRACCO INT BV [NL] · Granted Jun 18, 2009 · Expires Jun 13, 2029

    granted
  4. US 7547712

    Methods for decreasing the toxic effects of nicotine on fetuses in pregnant women

    United States of America as Represented by the Secretary, DHHS Office of Technology Transfer, National Institutes of Health · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  5. US 7547698

    Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)

    Xenon Pharmaceuticals Inc. · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  6. US 7547509

    Cyanovirin variant-polymer conjugates

    Nektar Therapeutics AL, Corporation · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  7. US 7547726

    AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  8. US 7547759

    Induction of tumor immunity by variants of folate binding protein

    The Board of Regents of the University of Texas System · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  9. US 7547773

    Nucleic acid molecules encoding prostate specific antigen oligo epitope peptides

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  10. US 7547806

    Tannate salt of rasagiline

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  11. US 7547546

    Progenitor cells from wharton's jelly of human umbilical cord

    Tissue Regeneration Therapeutics Inc. · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  12. US 7547716

    Sulfonamide derivatives

    Institute of Medicinal Molecular Design, Inc. · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  13. US 7547787

    Processes for preparing montelukast sodium

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  14. US 7547794

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  15. US 7547686

    Combretastatin A-3 prodrug

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  16. US 7547762

    T24 antigen for immunodiagnosis of Taenia solium cysticercosis

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  17. US 7544778

    Recombinant antigens for diagnosis and prevention of murine typhus

    United States of America as represented by the Secretary of the Air Force · Granted Jun 9, 2009 · Expires Jun 4, 2029

    granted
  18. US 7544661

    Self-assembling peptide amphiphiles and related methods for growth factor delivery

    Northwestern University · Granted Jun 9, 2009 · Expires Jun 4, 2029

    granted
  19. US 7544364

    Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin

    Theravance, Inc. · Granted Jun 9, 2009 · Expires Jun 4, 2029

    granted
  20. US 7544486

    Nell peptide expression systems and bone formation activity of nell peptide

    The Regents of the University of California · Granted Jun 9, 2009 · Expires Jun 4, 2029

    granted
  21. US 7544670

    HoxD3, HoxA3 and HoxB3 compositions and methods for improved wound healing

    The Regents of the University of California · Granted Jun 9, 2009 · Expires Jun 4, 2029

    granted
  22. US 7544738

    Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

    Nektar Therapeutics AL, Corporation · Granted Jun 9, 2009 · Expires Jun 4, 2029

    granted
  23. US 7544481

    Nucleic acids encoding CD40 binding protein

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 9, 2009 · Expires Jun 4, 2029

    granted
  24. US 7544713

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Jun 9, 2009 · Expires Jun 4, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.